Artal Group S.A. Hookipa Pharma Inc. Transaction History
Artal Group S.A.
- $1.86 Billion
- Q1 2024
A detailed history of Artal Group S.A. transactions in Hookipa Pharma Inc. stock. As of the latest transaction made, Artal Group S.A. holds 5,666,410 shares of HOOK stock, worth $3.63 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
5,666,410
Previous 5,666,410
-0.0%
Holding current value
$3.63 Million
Previous $4.02 Million
-0.0%
% of portfolio
0.22%
Previous 0.22%
Shares
8 transactions
Others Institutions Holding HOOK
# of Institutions
50Shares Held
32.5MCall Options Held
105KPut Options Held
43.6K-
Baker Bros. Advisors LP New York, NY8.13MShares$5.2 Million0.07% of portfolio
-
Knoll Capital Management, LLC Miami, FL5.52MShares$3.53 Million2.45% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA4.6MShares$2.94 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.12MShares$1.36 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.24MShares$793,6460.0% of portfolio
About HOOKIPA Pharma Inc.
- Ticker HOOK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,654,500
- Market Cap $33.1M
- Description
- HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transpl...